Home   >  
Angiogenesis/Protein Tyrosine Kinase
  >  
c Met

Classified by application

All Products

Signaling Pathways

Research Areas

Nature products

Antibodies

Peptides

Catalysts

Impurities

Intermediate

Raw Materials

c Met

Chemical Structure Cat. No. Product Name CAS No.
PF-04217903 phenolsulfonate Chemical Structure
 BCP36115 PF-04217903 phenolsulfonate 1159490-85-3
PF-04217903 phenolsulfonate is a potent ATP-competitive c-Met kinase inhibitor. It shows more than 1,000-fold selectivity relative to 208 kinases.PF-04217903 is a potent ATP-competitive c-Met kinase inhibitor with Ki of 4.8 nM for human c-Met.
ARQ 197 Chemical Structure
 BCP28549 ARQ 197 1000873-98-2
ARQ-197 is a selective inhibitor of the c-Met receptor tyrosine kinase
S49076 HCl Chemical Structure
 BCP35053 S49076 HCl 1265965-19-2
S49076 is a novel, potent inhibitor of MET, AXL/MER, and FGFR1/2/3 with IC50 values below 20 nM.
Bozitinib Chemical Structure
 BCP34901 Bozitinib 1440964-89-5
Bozitinib (PLB-1001) is a highly selective c-MET kinase inhibitor with blood-brain barrier permeability.
TAS-115 mesylate Chemical Structure
 BCP34015 TAS-115 mesylate 1688673-09-7
TAS-115 mesylate is a potent VEGFRand hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase inhibitor, with IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively.
TAS-115 Chemical Structure
 BCP34014 TAS-115 1190836-34-0
TAS-115 is a potent VEGFR and hepatocyte growth factor receptor (c-Met/HGFR)-targeted kinase inhibitor with IC50s of 30 and 32 nM for rVEGFR2 and rMET, respectively.
Glumetinib Chemical Structure
 BCP31155 Glumetinib 1642581-63-2
Glumetinib is a potent and highly selective c-Met kinase inhibitor with an IC50 of 0.42 nM. Glumetinib shows antitumor activity and a superior safety margin.
AMG51 Chemical Structure
 BCP21618 AMG51 890019-63-3
AMG-51 is a selective inhibitor of c-Met kinase
S49076 HCl Chemical Structure
 BCP29576 S49076 HCl 1265966-31-1
S49076 is an effective inhibitor of MET, AXL/MER, and FGFR1/2/3. S49076 potently blocked cellular phosphorylation of MET, AXL, and FGFRs and inhibited downstream signaling in vitro and in vivo.
SAR125844 Chemical Structure
 BCP28183 SAR125844 1116743-46-4
SAR125844 is a potent and highly selective c-Met inhibitor with potential antineoplastic activity.
123下一頁末頁共 50 條記錄 1 / 5 頁 
0086-13720134139
福建36选7奖金 星悦福建麻将官网下载 今日篮彩推荐预测 浙江飞鱼彩票开奖结果 在线棋牌游戏赚钱 亿客隆 新11选5万能公式 莱特币交易平台排名前十图片 打贵州麻将怎么算胡 jj德州扑克 大游bg视讯平台 福彩3d综合走势图 山东11选5购买群 股票风险指标 广西11选5技巧稳赚 维卡币骗局揭秘视频 四人麻将安装